"moderate" MCQ (SBA): Chronic Kidney Disease

Instant feedback + full explanation. One question, done properly.

Moderatefinerenone) reduce albuminuria and CV outcomes in T2D CKD on ACEi/ARB. Other agents lack this evidence."Chronic Kidney Disease"moderate"

A 70-year-old on lisinopril has persistent albuminuria (UACR 420 mg/g). Per ADA/KDIGO, adding which agent is evidence-based to reduce albuminuria and CV events?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.